Diabetes macular edema, a underestimated visual problem

May 13, 2014, Investigación y Desarrollo

In Mexico, at least 14 million people have developed macular edema due to diabetes (DME), which like retinopathy affects central vision and can lead to blindness if not treated early .

"There are no exact figures for the annual prevalence of people with macular degeneration related to in the country, but throughout the world eight thousand new cases of DME and related health problems are diagnosed each year," said Rafael Bueno, chief of Retina Service at the  General Hospital of the Ministry of Health in Mexico City.

A very sensitive area of the is called the macula, which contains a liquid that is vital to the efficient functioning of the eyeball; when this fluid tends to come out is called and can cause blindness in the patient. A reason, perhaps the main one, for the fluid in the macula to leak is the high level of glucose in blood.

It is not uncommon for diabetic macular edema to present after the onset of , a complex process of deterioration of the retina that produces the obstruction of blood vessels and the occurrence of bleeding, because of high levels of blood glucose. In an estimated of 70 percent of patients with diabetic retinopathy, macular edema will eventually develop.

Blurred vision is the symptom to consider as a possible appearance of and perception of floating particles, shadows or spots, along with a difficulty of seeing at night .

The ophthalmologist at General Hospital stressed the importance for patients to consult a retina specialist at the time they are diagnosed with diabetes and subsequently have an annual review of their vision, through examinations measuring eye pressure and visual acuity."

Furthermore, he stressed, the importance to follow a metabolic control to maintain normal glucose as well as cholesterol, triglycerides and .

A conventional therapy for treating macular edema is the application of laser, which allows to regulate the progression of the problem, but in some cases can be aggressive, since it causes burns to the retina that can cause the tissue to deteriorate to the point of destruction.

Nowadays the antiangiogenic therapy is feasible for the treatment of macular edema, which is based on drugs that are applied by an intraocular injection and slow the progression of the problem producing stabilization and improvement of lost lines of vision.

Dr. Rafael Bueno explained that many patients with macular are the children of patients who have had macular degeneration and to prevent it is important to visit the eye doctor starting at the age of 45, at least once a year, to value the risk of having DME.

"I wish we could prevent diabetes. Yet in Mexico we have a heavy genetic load and thus a child of a family with diabetes should be alert because surely at some point it will develop," said Rafael Bueno.

He recommends a balanced diet rich in green foods with vitamin A and eating foods rich in Omega 3 to combat the onset of related to age.

"We're seeing people developing diabetes at younger ages, it being a more aggressive and difficult to control disease; these patients, if they do not have adequate control of glucose levels, over time will develop vision problems," the expert added.

Explore further: Many people with diabetes still lose vision, despite availability of vision-sparing treatment

Related Stories

Many people with diabetes still lose vision, despite availability of vision-sparing treatment

December 19, 2013
Despite recent advances in prevention and treatment of most vision loss attributed to diabetes, a new study shows that fewer than half of Americans with damage to their eyes from diabetes are aware of the link between the ...

FDA approves drug to treat diabetic macular edema

August 13, 2012
The U.S. Food and Drug Administration today announced its approval of Lucentis (ranibizumab injection) for the treatment of diabetic macular edema, or DME, an eye condition in people with diabetes that causes blurred vision, ...

Diabetes leading to blindness in many people

November 30, 2012
Diabetes is the leading cause of new cases of blindness among adults 20 to 74 years old. Dr. Michael Grodin, co-director of retinal services and director of clinical research at Katzen Eye Group, with locations around Baltimore, ...

Sharp rise in diabetic eye disease makes American Diabetes Month ever more important

November 7, 2012
Diabetes is the leading cause of blindness among working-age adults in the United States. According to recent studies funded by the National Eye Institute (NEI), diabetic retinopathy, one of the most common and debilitating ...

Thiazolidinedione use in patients with Type 2 diabetes may increase risk for diabetic macular edema

June 11, 2012
Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.